「ma」の検索結果
171件：26～30件目を表示
-
March 7, 2025 General Announcement Senju Pharmaceutical Co., Ltd. Announcement of Licensing Agreement with Brill International Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307_0.pdf -
」 （LATACHIMO COMBINATION OPHTHALMIC SOLUTION「SENJU」） 一般名：ラタノプロスト (Latanoprost) チモロールマレイン酸塩 (Timolol Maleate) 含有量（１mL中）：ラタノプロスト 50μg チモロールマレイン酸塩 6.83mg (チモロールとして5mg) 患者向医薬品ガイドについて 患者向医薬品ガイドは、患者の皆様や家族の方...
https://www.senju.co.jp/system/files/medical_product_guide/2024-09/LTM_202409_05_Mguide.pdf -
General Announcement: September 6, 2024 Senju Pharmaceutical Co., Ltd. Launch of Distribution of Software for Dry-eye Analysis Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr...
https://www.senju.co.jp/system/files/content_news/2024-09/ENG_20240906_0.pdf -
General Announcement: July 8, 2024 Senju Pharmaceutical Co., Ltd. Notice of Orphan Drug Designation for SJP-0008 as a Treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Head...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708_0.pdf -
July 16, 2024 General Announcement: Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Senju has successfully completed Phase III clinical trials in Japan for the novel Dry Eye Disease tr...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716.pdf